Tenax Therapeutics DPO Ratio 2011-2026 | TENX

Annual DPO Ratio Tenax Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	-	-	-	1.16 K	8.27 K	3.87 K	1.48 K

All numbers in USD currency

Maximum	Minimum	Average
8.27 K	1.16 K	3.69 K

Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
I-Mab IMAB	2.24 K	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	78.2	-	-	$ 40.3 B	USA
Midatech Pharma plc MTP	162	-	-18.52 %	$ 27.3 M	Britain
Acorda Therapeutics ACOR	277	-	-24.86 %	$ 820 K	USA
Advaxis ADXS	143 K	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	34.4 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	9.04 K	-	-10.17 %	$ 12.2 K	USA
AIkido Pharma AIKI	1.92	-	1.93 %	$ 17.4 M	USA
Институт стволовых клеток человека ISKJ	115	-	-	-	Russia
AstraZeneca PLC AZN	265	-	-	$ 96.9 B	Britain
Ayala Pharmaceuticals AYLA	2.21 K	-	-	$ 7.46 M	Israel
BeiGene, Ltd. BGNE	915	-	0.49 %	$ 251 B	Cayman-islands
bluebird bio BLUE	182	-	-	$ 546 M	USA
Brickell Biotech BBI	105	-	-5.38 %	$ 6.06 M	USA
CASI Pharmaceuticals CASI	123	-	-	$ 35.4 M	USA
Ampio Pharmaceuticals AMPE	2.85 K	-	-11.43 %	$ 502 K	USA
Завод ДИОД DIOD	30.3	-	-	-	Russia
Фармсинтез LIFE	306	-	-	-	Russia
Chimerix CMRX	2.38 K	-	-	$ 756 M	USA
Teligent, Inc. TLGT	59.2	-	-13.85 %	$ 16.1 M	USA
AbbVie ABBV	65.5	$ 208.7	-0.07 %	$ 369 B	USA
Viela Bio, Inc. VIE	997	-	-	$ 2.91 B	USA